Company Performance Metrics
Shenzhen Watsin Genetech Co., Ltd. is a high-tech biopharmaceutical company that is engaged in the research, development, and production of gene engineering medicine.
Since its establishment in 1997, Watsin has been devoting itself to the development of biomedical and genetic industry, successfully developing a series of high-tech genetic
engineering products with independent intellectual property rights. The core project of the enterprise, the industrialization of rhEGF (recombinant human Epidermal Growth Factor), is a demonstrative project of the national high technology industrialization, which was approved by the National Development and Reform Commission in 2002.
Watsin has already come among the first national top one hundred enterprises with a GMP certification, and its total investment exceeds 10 million Yuan.
